![](/img/cover-not-exists.png)
Evidence-Based Development and Rationale for Once-Daily Rivaroxaban Dosing Regimens Across Multiple Indications
Kubitza, D., Berkowitz, S. D., Misselwitz, F.Language:
english
Journal:
Clinical and Applied Thrombosis/Hemostasis
DOI:
10.1177/1076029616631427
Date:
February, 2016
File:
PDF, 459 KB
english, 2016